Last reviewed · How we verify
RANITIDINE HYDROCHLORIDE
RANITIDINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 1983).
Ranitidine hydrochloride is a medication used to treat conditions such as dyspepsia and reflux oesophagitis. It is also being studied in clinical trials for other conditions including renal cell carcinoma and multiple myeloma.
At a glance
| Generic name | RANITIDINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1983 |
Approved indications
Common side effects
- Headache
- Constipation
- Diarrhea
- Nausea/Vomiting
- Abdominal discomfort/pain
Serious adverse events
- Hepatocellular, cholestatic, or mixed hepatitis
- Hepatic failure
- Aplastic anemia
- Agranulocytosis
- Pancytopenia
- Anaphylaxis
- Acute interstitial nephritis
- Pancreatitis
- Atrioventricular block
- Acquired immune hemolytic anemia
Key clinical trials
- Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer (PHASE2)
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (PHASE1)
- Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections (PHASE4)
- A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT (PHASE3)
- : Vascular Function in Health and Disease (PHASE1)
- Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation (PHASE1, PHASE2)
- Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel (PHASE2, PHASE3)
- Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RANITIDINE HYDROCHLORIDE CI brief — competitive landscape report
- RANITIDINE HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about RANITIDINE HYDROCHLORIDE
What is RANITIDINE HYDROCHLORIDE?
When was RANITIDINE HYDROCHLORIDE approved?
What development phase is RANITIDINE HYDROCHLORIDE in?
What are the side effects of RANITIDINE HYDROCHLORIDE?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing